Antitrypsin Deficiency Stocks List

Antitrypsin Deficiency Stocks Recent News

Date Stock Title
May 3 NTLA Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
May 3 ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
May 3 BAX Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript
May 3 ALNY Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
May 3 NTLA IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
May 3 ALNY Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
May 3 BAX Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 46% Undervaluation?
May 3 ALNY Alnylam Pharmaceuticals Inc (ALNY) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
May 3 BAX Baxter International Inc (BAX) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
May 2 BEAM Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
May 2 ALNY Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2024 Earnings Call Transcript
May 2 BAX Baxter International Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 ALNY Alnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 BAX Compared to Estimates, Baxter (BAX) Q1 Earnings: A Look at Key Metrics
May 2 BAX Baxter International Inc. (BAX) Q1 2024 Earnings Call Transcript
May 2 BAX Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
May 2 ALNY Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
May 2 ALNY Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
May 2 BAX Baxter International Inc (BAX) Surpasses Q1 Earnings and Revenue Estimates
May 2 BAX Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates
Antitrypsin Deficiency

Antitrypsin Deficiency is a genetic disorder that affects the lungs and liver. It is caused by a deficiency of the protein alpha-1 antitrypsin (AAT), which is produced in the liver and helps protect the lungs from damage. People with Antitrypsin Deficiency are at an increased risk of developing lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD). They may also be at risk of developing liver disease. Treatment for Antitrypsin Deficiency includes lifestyle changes, medications, and in some cases, a liver transplant.

Browse All Tags